While the White House focused its initial Section 232 pharmaceutical tariffs on branded drugs, generics makers—who supply the vast majority of U.S. prescriptions—won’t stay in the clear for long. In ...

More than a supply chain issue and missing the first mover status, Semaglutide episode has rather exposed systemic chinks and could prove costly for India’s pharmaceutical industry, which supplies ...

Experts believe the long-term impact may be less severe than the headline tariff numbers suggest. Trump proposes tariffs on imported generic drugs. India's generic exports to US face disruption.

Chennai: US President Donald Trump has given global drugmakers two years to shift generic medicine production to the US before imposing tariffs of 100% from Aug 2028 and 200% from Aug 2029. Even with ...

As the shadows lengthened over the Meadowlands, the 2026 World Cup final settled into its decisive rhythm: persistent, angled attacks by Spain, the European champions, in their attempt to take the ...

US President Donald Trump announced a 100% tariff on imported generic pharmaceutical drugs on Tuesday. The tariff, which aims to bolster US pharmaceutical production, is set to go into effect in ...

Troy Segal is an editor and writer. She has 20+ years of experience covering personal finance, wealth management, and business news. Toby Walters is a financial writer, investor, and lifelong learner.

Trump Says Generic Drugs to Face No US Tariffs for 2 Years, Then 100% and 200% Tariffs Later By Kanishka Singh WASHINGTON, July 21 (Reuters) - ⁠President ⁠Donald Trump said ⁠on Tuesday all generic ...

The administration has repeatedly said it will impose steep pharmaceutical tariffs but has not followed through on them. By Rebecca Robbins See more of our coverage in your search results.Encuentra ...

Trump plans tariffs of up to 200% on imported generic drugs after a two-year grace period aimed at encouraging U.S. manufacturing. But thin profit margins make tariffs harder to absorb than for ...

Donald Trump has said he intends to impose tariffs of 100% on generic drugs imported into the US from 2028, as part of a drive to reduce the country's reliance on imported medicines. One might be ...